Cyclosporine A Regulates Pro-Inflammatory Cytokine Production in Ulcerative Colitis-Reference-Cited by-同舟云学术

Cyclosporine A Regulates Pro-Inflammatory Cytokine Production in Ulcerative Colitis

Published:2014-08-26 Issue:1 Volume:63 Page:53-63
ISSN:0004-069X
Container-title:Archivum Immunologiae et Therapiae Experimentalis
language:en
Short-container-title:Arch. Immunol. Ther. Exp.

Author:

Steiner Stefanie,Daniel Carolin,Fischer Anika,Atreya Imke,Hirschmann Simon,Waldner Maximilian,Neumann Helmut,Neurath Markus,Atreya Raja,Weigmann Benno

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00005-014-0309-7.pdf

Reference53 articles.

1. Andersson J, Nagy S, Groth CG et al (1992) Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology 75:136–142

2. Atreya R, Zimmer M, Bartsch B et al (2011) Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14+ macrophages. Gastroenterology 141:2026–2038

3. Becker C, Watson AJ, Neurath MF (2013) Complex roles of caspases in the pathogenesis of inflammatory bowel disease. Gastroenterology 144:283–293

4. Boirivant M, Pica R, DeMaria R et al (1996) Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis. J Clin Invest 98:2616–2622

5. Brynskov J, Freund L, Norby Rasmussen S et al (1991) Final report on a placebo-controlled, double-blind, randomized, multicentre trial of cyclosporin treatment in active chronic Crohn’s disease. Scand J Gastroenterol 26:689–695

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutraceuticals in the Treatment of Inflammatory Bowel Disease: How the Panorama has Changed in the Last Decade?;Current Medicinal Chemistry;2023-06

2. Small but powerful: will nanoparticles be the future state‐of‐the‐art therapy for IBD?;Expert Opinion on Drug Delivery;2022-03-03

3. Pharmacokinetic Control by Particle Design Strategies Based on Polymeric Nanocarriers;Journal of the Society of Powder Technology, Japan;2021-06-10

4. Targeting T cells in inflammatory bowel disease;Pharmacological Research;2020-09

5. Traditional Drugs: Mechanisms of Immunosuppressor and Corticosteroid Therapies for Inflammatory Bowel Diseases;Biological Therapy for Inflammatory Bowel Disease;2020-03-11